0001203311-13-000080.txt : 20130905
0001203311-13-000080.hdr.sgml : 20130905
20130905175512
ACCESSION NUMBER: 0001203311-13-000080
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130903
FILED AS OF DATE: 20130905
DATE AS OF CHANGE: 20130905
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIEGALL CLAY B
CENTRAL INDEX KEY: 0001167496
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 131081322
MAIL ADDRESS:
STREET 1: 21823 30TH DR SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2013-09-03
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001167496
SIEGALL CLAY B
21823 30TH DRIVE SE
BOTHELL
WA
98021
1
1
0
0
President and CEO
Common Stock
2013-09-03
4
M
0
2000
10.33
A
1079211
D
Common Stock
2013-09-03
4
S
0
2000
42.7659
D
1077211
D
Common Stock
2013-09-03
4
S
0
100000
43.9227
D
977211
D
Non-Qualified Stock Option (right to buy)
10.33
2013-09-03
4
M
0
2000
0
D
2005-01-30
2014-02-17
Common Stock
2000
7858
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Siegall and described in a Form 8-K filed on June 15, 2012.
$42.7659 represents an average price per share for the shares sold on 9/3/2013. The sell price for shares sold on this day ranged from $42.66 to $42.88.
Amount of Securites beneficially owned following reported transactions includes 189,250 restricted Stock units subject to vesting.
$43.9227 represents an average price per share for the shares sold on 9/4/2013. The sell price for shares sold on this day ranged from $43.70 to $44.265.
25% of the shares vested on 1/30/05. The remainder vested monthly thereafter until all shares were full vested on 1/30/08.
Clay B. Siegall
2013-09-05